QuadMedicine, Inc. (KOSDAQ:464490)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,920
+880 (4.88%)
At close: Feb 27, 2026
-21.00%
Market Cap 217.24B
Revenue (ttm) 13.11B
Net Income (ttm) -5.49B
Shares Out 11.48M
EPS (ttm) -592.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,583,924
Average Volume 1,854,243
Open 18,200
Previous Close 18,040
Day's Range 17,770 - 20,300
52-Week Range 12,460 - 27,150
Beta n/a
RSI 49.75
Earnings Date n/a

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 464490
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.